Global Anticancer Drugs Market and its Future Outlook During the Period of 2018-2026

Press Release

Researchmoz added Most up-to-date research on “Global Market Study on Anticancer Drugs: Targeted Therapy Drug Class Anticipated to Exhibit Highest Revenue Contribution Through 2026” to its huge collection of research reports.

The Anticancer Drugs market report [8 Year Forecast 2018-2026] focuses on Major Leading Industry Players, providing info like company profiles, product type, application and regions, production capacity, ex-factory price, gross margin, revenue, market share and speak to info. Upstream raw materials and instrumentation and downstream demand analysis is additionally administrated. The Anticancer Drugs market business development trends and selling channels square measure analyzed. From a global perspective, It also represents overall Anticancer Drugs industry size by analyzing qualitative insights and historical data.

Get Free PDF for more Professional and Technical insights @

The global anticancer drugs market is expected to yield impressive gains owing to the increasing prevalence of cancer. According to the World Health Organization, the number of global cancer deaths is projected to increase by 45% by 2030, with 70% of the cancer deaths expected to occur in low and middle income countries. Mortality from cancer is projected to reach over 13 million in 2030, while, the number of new cancer cases is expected to increase more than 80% in low-income countries, almost double the 40% rate anticipated in high-income countries by 2030.

The global anticancer drugs market has witnessed a paradigmatic shift from administering highly toxic drugs to targeted personalized therapy with lower side effects. There is an upsurge in adoption of biologics especially monoclonal antibodies. New drug development has achieved high importance owing to emergence of difficulties to treat cancers such as small cell lung cancer. The increase in the number of clinical trials coupled with the growing research and development expenditures has resulted in an buildup of impressive new drug pipeline, which is expected to confer large future market equity for the global anticancer drugs market.

The Global Anticancer Drugs Market has been Segmented Based on:

Drug Class
Distribution Channels

The report analyzes the anticancer drugs market based on regions and presents the forecast in terms of value (US$ Mn) for the next 08 years. The regions covered in the report include:

North America
Latin America
Asia-Pacific Excluding Japan
Middle East & Africa

The next section of report analyzes the anticancer drugs market based on drug class and presents the forecast in terms of value for the next 8 years. The drug class covered in the report include:

Hormonal Therapy
Targeted Therapy
Monoclonal antibodies
Small molecule inhibitors

Make an Enquiry of this Report @

The next section of report analyzes the anticancer drugs market based on distribution channel for anticancer drugs products and provides forecast in terms of value for the next 8 years. The distribution channels covered in the report include:

Hospital Pharmacies
Retail Pharmacies

Another key feature of this report is the analysis of the key segments in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective of the products. To understand the key growth segments, Persistence Market Research provides the Attractiveness Index analysis, which helps to identify the real market opportunities.

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Contact Us:

Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
Toll Free: 866-997-4948 (US-CANADA)
Email: [email protected]
Follow us on LinkedIn @
Follow us on Blogger @